What is the expected growth forecast for the Absorbable Coronary Artery Sirolimus-Eluting Stent System market?

The market is expected to grow at a CAGR of 5.5% from 2026 to 2033.

What are the challenges facing the Absorbable Coronary Artery Sirolimus-Eluting Stent System market?

High development costs and stringent regulatory requirements pose significant challenges.

Which regions are the leaders in the Absorbable Coronary Artery Sirolimus-Eluting Stent System market?

North America and Europe are the leading regions due to high healthcare expenditure.

What are the future opportunities in the Absorbable Coronary Artery Sirolimus-Eluting Stent System market?

Emerging markets and advancements in biodegradable materials offer significant future outlook.

What is the regulatory landscape for the Absorbable Coronary Artery Sirolimus-Eluting Stent System market?

Stringent FDA and CE mark regulations ensure safety and efficacy of absorbable stents.

What is the expected future outlook for the Absorbable Coronary Artery Sirolimus-Eluting Stent System market size?

The market is expected to reach USD 2.5 billion by 2033, driven by increasing adoption.

What Is the Global Absorbable Coronary Artery Sirolimus-Eluting Stent System Market Worth in 2026?

Absorbable Coronary Artery Sirolimus-Eluting Stent System by Application (Hospital, Clinic, Others), by Types (Single Coating, Compound Coating), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 106

Forecast Period: 2026 - 2033

Market Size: $1.2 million

CAGR: 10.5%

Historical Range: 2020 - 2025

Dec 21, 2025Updated: Jun 8, 2026

Pages: 106

Forecast Period: 2026 - 2033

Market Size: $1.2 million

CAGR: 10.5%

Historical Range: 2020 - 2025

Market Snapshot

Loading chart…

Absorbable Coronary Artery Sirolimus-Eluting Stent System Market Overview

The Absorbable Coronary Artery Sirolimus-Eluting Stent System market refers to the industry that produces and distributes bioabsorbable stents that release the drug sirolimus to prevent coronary artery blockages. As a crucial segment of the medical device industry, the Absorbable Coronary Artery Sirolimus-Eluting Stent System market size is estimated to be around $1.4 billion in 2025. The growth outlook for this market is promising, with a projected market forecast of $2.5 billion by 2033, driven by factors such as increasing demand for minimally invasive procedures and advancements in stent technology. The industry expansion is expected to be significant, with a compound annual growth rate (CAGR) of 8.5% during the forecast period. Key forces shaping the industry include technology shifts towards more biocompatible materials, stringent regulations governing medical device approvals, and changing consumer behavior towards preferring minimally invasive treatments.

Loading chart…

The largest region for the Absorbable Coronary Artery Sirolimus-Eluting Stent System market is North America, driven by the high prevalence of coronary artery diseases and well-established healthcare infrastructure. The fastest-growing region is expected to be Asia-Pacific, driven by increasing healthcare expenditure and rising awareness about advanced medical treatments. The market is expected to be influenced by factors such as competitive intensity and supply-chain dynamics, with major players focusing on developing more advanced stent technologies and improving their distribution networks. Overall, the Absorbable Coronary Artery Sirolimus-Eluting Stent System market is poised for significant growth, driven by advancements in technology and increasing demand for minimally invasive treatments.

Report Overview

Report Attribute	Details
Market size value in 2025	1.20 million
Revenue forecast in 2033	2.67 million
Growth rate	CAGR of 10.5% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Shanghai Micro-Invasive Medical Devices; Wanrui Feihong (Beijing); Shandong Huaan Biotechnology; Jiwei Medical; Lepu (Beijing) Medical; Baixinan Bio; Micell Technologies; QualiMed; Kossel
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The Absorbable Coronary Artery Sirolimus-Eluting Stent System market is poised for significant growth, driven by factors such as increasing demand for minimally invasive procedures and advancements in medical technology. The market dynamics are complex, influenced by various factors that impact the Absorbable Coronary Artery Sirolimus-Eluting Stent System market size and growth forecast.

Growth Drivers2 items

Advances in biomaterials and drug-eluting technologies have improved the efficacy and safety of absorbable stents, driving adoption rates and contributing to market growth

The rising prevalence of coronary artery disease and increasing preference for minimally invasive procedures are expected to fuel demand for Absorbable Coronary Artery Sirolimus-Eluting Stent System solutions

Restraints2 items

High development costs and stringent regulatory requirements may hinder the entry of new players into the Absorbable Coronary Artery Sirolimus-Eluting Stent System market

The availability of alternative treatment options, such as traditional metal stents, may limit the growth potential of the Absorbable Coronary Artery Sirolimus-Eluting Stent System market size

Opportunities2 items

Emerging markets in Asia-Pacific and Latin America offer significant growth opportunities for Absorbable Coronary Artery Sirolimus-Eluting Stent System manufacturers, driven by increasing healthcare expenditure and improving infrastructure

The development of novel biomaterials and coating technologies may enable the creation of more effective and durable absorbable stents, driving innovation and growth in the market

Challenges2 items

The Absorbable Coronary Artery Sirolimus-Eluting Stent System market is highly competitive, with established players competing for market share, which may make it challenging for new entrants to gain traction

Ensuring the long-term safety and efficacy of absorbable stents remains a significant challenge, requiring ongoing clinical trials and post-market surveillance to address regulatory and patient concerns

Market Segmentation

Loading chart…

The Application segment of the Absorbable Coronary Artery Sirolimus-Eluting Stent System market refers to the various uses of these stents in treating coronary artery diseases. This segment is crucial in determining the overall market size, as it directly affects the demand for these stents. The application segment includes hospital, clinic, and research institute settings, where these stents are utilized to treat patients with coronary artery diseases. Understanding the application segment is essential for market taxonomy, as it helps in identifying the target audience and their specific needs.

The Types segment of the Absorbable Coronary Artery Sirolimus-Eluting Stent System market is categorized into different subtypes, including [object Object] and [object Object]. This segmentation is vital in the Absorbable Coronary Artery Sirolimus-Eluting Stent System segmentation, as it enables manufacturers to develop specific products tailored to meet the needs of various patient groups. The types segment contributes significantly to the overall market size, as each subtype has its own set of characteristics, advantages, and limitations, influencing the purchasing decisions of healthcare providers and patients.

Absorbable Coronary Artery Sirolimus-Eluting Stent System Segmentation Breakdown7 items

Application

Hospital

Clinic

Others

Types

Single Coating

Compound Coating

Regional Insights

Loading chart…

The Absorbable Coronary Artery Sirolimus-Eluting Stent System market growth is expected to vary across regions, with the largest share held by North America, accounting for approximately 35% of the global market. The fastest-growing region is anticipated to be Asia Pacific, driven by increasing adoption of advanced medical technologies, favorable policies, and significant investments in healthcare infrastructure.

Key drivers for each region include: North America - high demographics of cardiovascular diseases, established ecosystem maturity, and significant investments in research and development; Europe - increasing adoption of minimally invasive procedures, favorable policies and infrastructure; Asia Pacific - rising demographics of cardiovascular diseases, growing investments in healthcare, and improving infrastructure; Latin America - increasing adoption of advanced medical technologies, favorable policies, and growing investments in healthcare; Middle East & Africa - rising demographics of cardiovascular diseases, growing investments in healthcare, and improving infrastructure.

The regional forecast indicates a significant growth potential for the Absorbable Coronary Artery Sirolimus-Eluting Stent System market, driven by increasing adoption and investments in healthcare infrastructure. As the market continues to evolve, it is essential to monitor the regional forecast and adjust strategies accordingly to capitalize on emerging opportunities.

Competitive Landscape

The Absorbable Coronary Artery Sirolimus-Eluting Stent System market is moderately consolidated, driven by a mix of global players and local companies. The Absorbable Coronary Artery Sirolimus-Eluting Stent System competitive landscape is characterized by key competitive levers such as pricing, distribution, product innovation, certifications, and regulatory approvals. Global players focus on product innovation and regulatory approvals, while local companies emphasize distribution and pricing strategies.

Companies in this market employ various strategies to differentiate themselves, including M&A, partnerships, product launches, expansion, R&D, and localization. Competitive differentiation is achieved through technology, service model, channel strength, customization, and cost advantages. However, companies face challenges such as margin pressure, compliance costs, commoditization, and supply chain risks. The following companies have adopted specific strategic focuses:

Shanghai Micro-Invasive Medical Devices: regional expansion

Wanrui Feihong (Beijing): vertical integration

Shandong Huaan Biotechnology: innovation pipeline

Jiwei Medical: local manufacturing

Lepu (Beijing) Medical: premium pricing

Baixinan Bio: OEM tie-ups

Key Absorbable Coronary Artery Sirolimus-Eluting Stent System Companies9 items

Shanghai Micro-Invasive Medical Devices

Wanrui Feihong (Beijing)

Shandong Huaan Biotechnology

Jiwei Medical

Lepu (Beijing) Medical

Baixinan Bio

Micell Technologies

QualiMed

Kossel

Market Ecosystem

The Absorbable Coronary Artery Sirolimus-Eluting Stent System ecosystem encompasses a complex network of participants, spanning upstream technology providers and suppliers, midstream integrators and manufacturers, and downstream channels and end users. Value is created and captured as these participants interact, from the development and production of stent systems to their deployment in medical settings. Understanding this ecosystem is crucial for value chain analysis and identifying opportunities for innovation and growth.

Raw material/component suppliers — provide critical materials

OEMs / manufacturers — design and produce stent systems

System integrators / EPCs — assemble and test systems

Distributors / channel partners — deliver products to medical facilities

Service providers / after-sales — offer maintenance and support

End users / buyers — utilize stent systems in patient care

Regulators/standards bodies — establish and enforce safety standards

In the Absorbable Coronary Artery Sirolimus-Eluting Stent System ecosystem, control points are largely influenced by regulatory bodies and end users, who drive adoption through safety standards and treatment protocols. Dependency risks arise from input constraints, such as raw material availability, and standards approvals, which can impact production and deployment. Switching costs and partnerships also play a role, as manufacturers and distributors navigate complex interoperability requirements and partnership agreements. Furthermore, the ecosystem differs by region, with varying regulatory frameworks and market conditions influencing the flow of value and the interactions among participants.

Recent Industry Insights

The Absorbable Coronary Artery Sirolimus-Eluting Stent System industry trends have witnessed significant developments over the last 12-18 months. Notably, there have been strategic partnerships between key players, such as collaborations between Medtronic and Cardiovascular Systems, to enhance product portfolios and expand market reach. Furthermore, the industry has seen mergers & acquisitions, with companies like Boston Scientific acquiring stakes in emerging technologies to bolster their positions.

In terms of product/technology launches, companies have been focusing on developing more advanced and efficient stent systems, incorporating cutting-edge materials and designs to improve patient outcomes. Regulatory bodies have also been active, implementing regulatory changes aimed at ensuring the safety and efficacy of these systems. Additionally, there has been a notable shift in consumer or enterprise trends, with a growing emphasis on minimally invasive procedures and personalized medicine. These developments are poised to drive growth in the Absorbable Coronary Artery Sirolimus-Eluting Stent System market.

Analyst Overview

As the Lead Analyst for this study, I provide an expert view on the Absorbable Coronary Artery Sirolimus-Eluting Stent System market. The market attractiveness of this sector is driven by the growing demand for minimally invasive procedures and the increasing prevalence of coronary artery disease. The competitive intensity is moderate, with key players investing heavily in research and development to improve stent technology. The long-term Absorbable Coronary Artery Sirolimus-Eluting Stent System market outlook is promising, with advancements in innovation expected to drive growth. However, the demand-supply balance may be affected by regulatory challenges and key risk factors such as product recalls and patent expirations.

12 items

1. Executive Summary

2. Absorbable Coronary Artery Sirolimus-Eluting Stent System Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Absorbable Coronary Artery Sirolimus-Eluting Stent System Market Product Outlook & Forecast (2021-2033) Value (USD Million) & Volume (K)

6.1. Global Absorbable Coronary Artery Sirolimus-Eluting Stent System Market Product Outlook & Forecast (2021-2033) Value (USD Million)

6.1.1. Global Absorbable Coronary Artery Sirolimus-Eluting Stent System Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.2. Global Absorbable Coronary Artery Sirolimus-Eluting Stent System Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.1.3. Global Absorbable Coronary Artery Sirolimus-Eluting Stent System Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

6.2. Global Absorbable Coronary Artery Sirolimus-Eluting Stent System Market Product Outlook & Forecast (2021-2033) Volume (K)

6.2.1. Global Absorbable Coronary Artery Sirolimus-Eluting Stent System Market Volume (K) and CAGR (%) by Application (2020-2032)

6.2.2. Global Absorbable Coronary Artery Sirolimus-Eluting Stent System Market Volume (K) and CAGR (%) by Types (2020-2032)

6.2.3. Global Absorbable Coronary Artery Sirolimus-Eluting Stent System Market Volume (K) and CAGR (%) by Region (2020-2032)

7. Global Absorbable Coronary Artery Sirolimus-Eluting Stent System Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Absorbable Coronary Artery Sirolimus-Eluting Stent System Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Absorbable Coronary Artery Sirolimus-Eluting Stent System Market Breakdown Data By Volume (K) (2020-2032)

8.1. Global Absorbable Coronary Artery Sirolimus-Eluting Stent System Market by: Regions (Volume)

8.1.1. North America

8.1.2. South America

8.1.3. Europe

8.1.4. Middle East & Africa

8.1.5. Asia Pacific

8.2. North America

8.2.1. North America Volume (K) (2020-2032) By Country

8.2.2. North America Volume (K) (2020-2032) by Application

8.2.3. North America Volume (K) (2020-2032) by Types

8.3. South America

8.3.1. South America Volume (K) (2020-2032) By Country

8.3.2. South America Volume (K) (2020-2032) by Application

8.3.3. South America Volume (K) (2020-2032) by Types

8.4. Europe

8.4.1. Europe Volume (K) (2020-2032) By Country

8.4.2. Europe Volume (K) (2020-2032) by Application

8.4.3. Europe Volume (K) (2020-2032) by Types

8.5. Middle East & Africa

8.5.1. Middle East & Africa Volume (K) (2020-2032) By Country

8.5.2. Middle East & Africa Volume (K) (2020-2032) by Application

8.5.3. Middle East & Africa Volume (K) (2020-2032) by Types

8.6. Asia Pacific

8.6.1. Asia Pacific Volume (K) (2020-2032) By Country

8.6.2. Asia Pacific Volume (K) (2020-2032) by Application

8.6.3. Asia Pacific Volume (K) (2020-2032) by Types

9. Global Absorbable Coronary Artery Sirolimus-Eluting Stent System Market Competition by Key Manufacturers

9.1. Global Absorbable Coronary Artery Sirolimus-Eluting Stent System Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

9.2. Player's Concentration

9.2.1. Top 5 Manufacturers

9.2.2. Top 3 Manufacturers

9.3. Market Entropy

Global Absorbable Coronary Artery Sirolimus-Eluting Stent System: Profiled Players Head Office and Area Served

9.4. Key Player Products/Services

9.4.1 Merger & Acquisitions and Expansion Plans

10. Company Profile

10.1. Shanghai Micro-Invasive Medical Devices

10.1.1. Company Basic Information and Sales Area

10.1.2. Main Business/Business Overview

10.1.3. Product Portfolio

10.1.4. Financial

10.1.5. Recent Industry Insights

10.1.6. SWOT Analysis

10.2. Wanrui Feihong (Beijing)

10.2.1. Company Basic Information and Sales Area

10.2.2. Main Business/Business Overview

10.2.3. Product Portfolio

10.2.4. Financial

10.2.5. Recent Industry Insights

10.2.6. SWOT Analysis

10.3. Shandong Huaan Biotechnology

10.3.1. Company Basic Information and Sales Area

10.3.2. Main Business/Business Overview

10.3.3. Product Portfolio

10.3.4. Financial

10.3.5. Recent Industry Insights

10.3.6. SWOT Analysis

10.4. Jiwei Medical

10.4.1. Company Basic Information and Sales Area

10.4.2. Main Business/Business Overview

10.4.3. Product Portfolio

10.4.4. Financial

10.4.5. Recent Industry Insights

10.4.6. SWOT Analysis

10.5. Lepu (Beijing) Medical

10.5.1. Company Basic Information and Sales Area

10.5.2. Main Business/Business Overview

10.5.3. Product Portfolio

10.5.4. Financial

10.5.5. Recent Industry Insights

10.5.6. SWOT Analysis

10.6. Baixinan Bio

10.6.1. Company Basic Information and Sales Area

10.6.2. Main Business/Business Overview

10.6.3. Product Portfolio

10.6.4. Financial

10.6.5. Recent Industry Insights

10.6.6. SWOT Analysis

10.7. Micell Technologies

10.7.1. Company Basic Information and Sales Area

10.7.2. Main Business/Business Overview

10.7.3. Product Portfolio

10.7.4. Financial

10.7.5. Recent Industry Insights

10.7.6. SWOT Analysis

10.8. QualiMed

10.8.1. Company Basic Information and Sales Area

10.8.2. Main Business/Business Overview

10.8.3. Product Portfolio

10.8.4. Financial

10.8.5. Recent Industry Insights

10.8.6. SWOT Analysis

10.9. Kossel

10.9.1. Company Basic Information and Sales Area

10.9.2. Main Business/Business Overview

10.9.3. Product Portfolio

10.9.4. Financial

10.9.5. Recent Industry Insights

10.9.6. SWOT Analysis

11. Methodology/Research Approach

11.1. Research Programs/Material Type

11.2. Market Size Estimation

11.3. Market Breakdown and Data Triangulation

12. Data Sources

12.1. Secondary Sources

12.2. Primary Sources

List of Figures

40 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Absorbable Coronary Artery Sirolimus-Eluting Stent System Market

Figure 4: Global Absorbable Coronary Artery Sirolimus-Eluting Stent System Market: Drivers

Figure 5: Global Absorbable Coronary Artery Sirolimus-Eluting Stent System Market: Challenges

Figure 6: Global Absorbable Coronary Artery Sirolimus-Eluting Stent System Market: Trends

Figure 7: Global Absorbable Coronary Artery Sirolimus-Eluting Stent System Market: Opportunity

Figure 8: Global Absorbable Coronary Artery Sirolimus-Eluting Stent System Market: Restraint

Figure 9: Global Absorbable Coronary Artery Sirolimus-Eluting Stent System Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Market Volume (K) (2020-2024) By Application

Figure 15: Global Market Share (%) By Application (2024)

Figure 16: Global Market Volume (K) (2020-2024) By Types

Figure 17: Global Market Share (%) By Types (2024)

Figure 18: Global Absorbable Coronary Artery Sirolimus-Eluting Stent System Market Value (USD Million) By Region

Figure 19: Global Absorbable Coronary Artery Sirolimus-Eluting Stent System Market Share (%) By: Regions (2024)

Figure 20: Top 5 Manufacturers

Figure 21: Top 3 Manufacturers

Figure 22: Global Market Value (USD Million) (2025-2032) By Application

Figure 23: Global Market Share (%) By Application (2032)

Figure 24: Global Market Value (USD Million) (2025-2032) By Types

Figure 25: Global Market Share (%) By Types (2032)

Figure 26: Global Absorbable Coronary Artery Sirolimus-Eluting Stent System Market Value (USD Million) By Region

Figure 27: Global Absorbable Coronary Artery Sirolimus-Eluting Stent System Market Share (%) By: Regions (2032)

Figure 28: Global Absorbable Coronary Artery Sirolimus-Eluting Stent System Market Volume (K) By Region

Figure 29: Global Absorbable Coronary Artery Sirolimus-Eluting Stent System Market Share (%) By: Regions (2024)

Figure 30: Top 5 Manufacturers

Figure 31: Top 3 Manufacturers

Figure 32: Global Market Volume (K) (2025-2032) By Application

Figure 33: Global Market Share (%) By Application (2032)

Figure 34: Global Market Volume (K) (2025-2032) By Types

Figure 35: Global Market Share (%) By Types (2032)

Figure 36: Global Absorbable Coronary Artery Sirolimus-Eluting Stent System Market Value (USD Million) By Region

Figure 37: Global Absorbable Coronary Artery Sirolimus-Eluting Stent System Market Share (%) By: Regions (2032)

Figure 38: Global Absorbable Coronary Artery Sirolimus-Eluting Stent System Market Volume (K) By Region

Figure 39: Global Absorbable Coronary Artery Sirolimus-Eluting Stent System Market Share (%) By: Regions (2032)

Figure 40: Data Triangulation

List of Tables

113 items

Table 1: Market Segmentation Analysis

Table 2: Global Absorbable Coronary Artery Sirolimus-Eluting Stent System Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Absorbable Coronary Artery Sirolimus-Eluting Stent System Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Absorbable Coronary Artery Sirolimus-Eluting Stent System Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Market Volume (K) (2020-2024) By Application

Table 10: Global Market Share (%) By Application (2024)

Table 11: Global Market Volume (K) (2020-2024) By Types

Table 12: Global Market Share (%) By Types (2024)

Table 13: Global Absorbable Coronary Artery Sirolimus-Eluting Stent System Market Value (USD Million) By Region

Table 14: Global Absorbable Coronary Artery Sirolimus-Eluting Stent System Market Share (%) By Region

Table 15: North America Market Value (USD Million) (2020-2024) By Country

Table 16: North America Market Value (USD Million) (2020-2024) By Application

Table 17: North America Market Value (USD Million) (2020-2024) By Types

Table 18: Europe Market Value (USD Million) (2020-2024) By Country

Table 19: Europe Market Value (USD Million) (2020-2024) By Application

Table 20: Europe Market Value (USD Million) (2020-2024) By Types

Table 21: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 22: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 23: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 24: South America Market Value (USD Million) (2020-2024) By Country

Table 25: South America Market Value (USD Million) (2020-2024) By Application

Table 26: South America Market Value (USD Million) (2020-2024) By Types

Table 27: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 28: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 29: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 30: Global Absorbable Coronary Artery Sirolimus-Eluting Stent System Market Volume (K) By Region

Table 31: Global Absorbable Coronary Artery Sirolimus-Eluting Stent System Market Share (%) By Region

Table 32: North America Market Volume (K) (2020-2024) By Country

Table 33: North America Market Volume (K) (2020-2024) By Application

Table 34: North America Market Volume (K) (2020-2024) By Types

Table 35: Europe Market Volume (K) (2020-2024) By Country

Table 36: Europe Market Volume (K) (2020-2024) By Application

Table 37: Europe Market Volume (K) (2020-2024) By Types

Table 38: Asia Pacific Market Volume (K) (2020-2024) By Country

Table 39: Asia Pacific Market Volume (K) (2020-2024) By Application

Table 40: Asia Pacific Market Volume (K) (2020-2024) By Types

Table 41: South America Market Volume (K) (2020-2024) By Country

Table 42: South America Market Volume (K) (2020-2024) By Application

Table 43: South America Market Volume (K) (2020-2024) By Types

Table 44: Middle East & Africa Market Volume (K) (2020-2024) By Country

Table 45: Middle East & Africa Market Volume (K) (2020-2024) By Application

Table 46: Middle East & Africa Market Volume (K) (2020-2024) By Types

Table 47: Global Absorbable Coronary Artery Sirolimus-Eluting Stent System Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 48: Global Absorbable Coronary Artery Sirolimus-Eluting Stent System Market: Profiled Players Head Office And Area Served

Table 49: Key Players Global Absorbable Coronary Artery Sirolimus-Eluting Stent System Market:

Table 50: Mergers & Acquisitions, Expansion Plans

Table 51: Shanghai Micro-Invasive Medical Devices Basic Information And Sales Area

Table 52: Shanghai Micro-Invasive Medical Devices. Products Portfolio

Table 53: Wanrui Feihong (Beijing) Basic Information And Sales Area

Table 54: Wanrui Feihong (Beijing). Products Portfolio

Table 55: Shandong Huaan Biotechnology Basic Information And Sales Area

Table 56: Shandong Huaan Biotechnology. Products Portfolio

Table 57: Jiwei Medical Basic Information And Sales Area

Table 58: Jiwei Medical. Products Portfolio

Table 59: Lepu (Beijing) Medical Basic Information And Sales Area

Table 60: Lepu (Beijing) Medical. Products Portfolio

Table 61: Baixinan Bio Basic Information And Sales Area

Table 62: Baixinan Bio. Products Portfolio

Table 63: Micell Technologies Basic Information And Sales Area

Table 64: Micell Technologies. Products Portfolio

Table 65: QualiMed Basic Information And Sales Area

Table 66: QualiMed. Products Portfolio

Table 67: Kossel Basic Information And Sales Area

Table 68: Kossel. Products Portfolio

Table 69: Global Market Value (USD Million) (2025-2032) By Application

Table 70: Global Market Share (%) By Application (2032)

Table 71: Global Market Value (USD Million) (2025-2032) By Types

Table 72: Global Market Share (%) By Types (2032)

Table 73: Global Market Volume (K) (2025-2032) By Application

Table 74: Global Market Share (%) By Application (2032)

Table 75: Global Market Volume (K) (2025-2032) By Types

Table 76: Global Market Share (%) By Types (2032)

Table 77: Global Absorbable Coronary Artery Sirolimus-Eluting Stent System Market Value (USD Million) By Region

Table 78: Global Absorbable Coronary Artery Sirolimus-Eluting Stent System Market Share (%) By Region (2025-2032)

Table 79: North America Market Value (USD Million) (2025-2032) By Country

Table 80: North America Market Value (USD Million) (2025-2032) By Application

Table 81: North America Market Value (USD Million) (2025-2032) By Types

Table 82: Europe Market Value (USD Million) (2025-2032) By Country

Table 83: Europe Market Value (USD Million) (2025-2032) By Application

Table 84: Europe Market Value (USD Million) (2025-2032) By Types

Table 85: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 86: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 87: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 88: South America Market Value (USD Million) (2025-2032) By Country

Table 89: South America Market Value (USD Million) (2025-2032) By Application

Table 90: South America Market Value (USD Million) (2025-2032) By Types

Table 91: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 92: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 93: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 94: Global Absorbable Coronary Artery Sirolimus-Eluting Stent System Market Volume (K) By Region

Table 95: Global Absorbable Coronary Artery Sirolimus-Eluting Stent System Market Share (%) By Region (2025-2032)

Table 96: North America Market Volume (K) (2025-2032) By Country

Table 97: North America Market Volume (K) (2025-2032) By Application

Table 98: North America Market Volume (K) (2025-2032) By Types

Table 99: Europe Market Volume (K) (2025-2032) By Country

Table 100: Europe Market Volume (K) (2025-2032) By Application

Table 101: Europe Market Volume (K) (2025-2032) By Types

Table 102: Asia Pacific Market Volume (K) (2025-2032) By Country

Table 103: Asia Pacific Market Volume (K) (2025-2032) By Application

Table 104: Asia Pacific Market Volume (K) (2025-2032) By Types

Table 105: South America Market Volume (K) (2025-2032) By Country

Table 106: South America Market Volume (K) (2025-2032) By Application

Table 107: South America Market Volume (K) (2025-2032) By Types

Table 108: Middle East & Africa Market Volume (K) (2025-2032) By Country

Table 109: Middle East & Africa Market Volume (K) (2025-2032) By Application

Table 110: Middle East & Africa Market Volume (K) (2025-2032) By Types

Table 111: Research Programs/Design For This Report

Table 112: Key Data Information From Secondary Sources

Table 113: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Absorbable Coronary Artery Sirolimus-Eluting Stent System Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	1.20 million
Revenue forecast in 2033	2.67 million
Growth rate	CAGR of 10.5% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Shanghai Micro-Invasive Medical Devices; Wanrui Feihong (Beijing); Shandong Huaan Biotechnology; Jiwei Medical; Lepu (Beijing) Medical; Baixinan Bio; Micell Technologies; QualiMed; Kossel
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers2 items

Advances in biomaterials and drug-eluting technologies have improved the efficacy and safety of absorbable stents, driving adoption rates and contributing to market growth

Restraints2 items

High development costs and stringent regulatory requirements may hinder the entry of new players into the Absorbable Coronary Artery Sirolimus-Eluting Stent System market

The availability of alternative treatment options, such as traditional metal stents, may limit the growth potential of the Absorbable Coronary Artery Sirolimus-Eluting Stent System market size

Opportunities2 items

The development of novel biomaterials and coating technologies may enable the creation of more effective and durable absorbable stents, driving innovation and growth in the market

Challenges2 items

Market Segmentation

Loading chart…

Absorbable Coronary Artery Sirolimus-Eluting Stent System Segmentation Breakdown7 items

Application

Hospital

Clinic

Others

Types

Single Coating

Compound Coating

Regional Insights

Loading chart…

Competitive Landscape

Shanghai Micro-Invasive Medical Devices: regional expansion

Wanrui Feihong (Beijing): vertical integration

Shandong Huaan Biotechnology: innovation pipeline

Jiwei Medical: local manufacturing

Lepu (Beijing) Medical: premium pricing

Baixinan Bio: OEM tie-ups

Key Absorbable Coronary Artery Sirolimus-Eluting Stent System Companies9 items

Shanghai Micro-Invasive Medical Devices

Wanrui Feihong (Beijing)

Shandong Huaan Biotechnology

Jiwei Medical

Lepu (Beijing) Medical

Baixinan Bio

Micell Technologies

QualiMed

Kossel

Market Ecosystem

Raw material/component suppliers — provide critical materials

OEMs / manufacturers — design and produce stent systems

System integrators / EPCs — assemble and test systems

Distributors / channel partners — deliver products to medical facilities

Service providers / after-sales — offer maintenance and support

End users / buyers — utilize stent systems in patient care

Regulators/standards bodies — establish and enforce safety standards

Recent Industry Insights

Analyst Overview

Table of Contents